心力衰竭
期限(时间)
心脏病学
医学
内科学
中国
物理
政治学
量子力学
法学
作者
Xian-Qiang Wang,Xingtong Zhou,Haibo Chen,Juan Du,Ping Qing,Liang Zou,Yi Chen,Fujian Duan,Su Yuan,Jia Shi,Bingyang Ji,Rong Wu,Yanming Zhang,Yan Jin,Shengshou Hu
标识
DOI:10.1016/j.healun.2024.05.004
摘要
Left ventricular assist devices (LVADs) are well-established for treating end-stage heart failure, but this therapy is only available to Chinese patients in recent years. The CH-VAD is the first used fully magnetically levitated pump and the most widely used device in China. This study reports the long-term outcomes of a cohort supported by the CH-VAD for the first time.
科研通智能强力驱动
Strongly Powered by AbleSci AI